These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33466790)

  • 21. The importance of regulatory ubiquitination in cancer and metastasis.
    Gallo LH; Ko J; Donoghue DJ
    Cell Cycle; 2017 Apr; 16(7):634-648. PubMed ID: 28166483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site.
    Paiva SL; da Silva SR; de Araujo ED; Gunning PT
    J Med Chem; 2018 Jan; 61(2):405-421. PubMed ID: 28076680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust high-throughput assays to assess discrete steps in ubiquitination and related cascades.
    Fenteany G; Gaur P; Sharma G; Pintér L; Kiss E; Haracska L
    BMC Mol Cell Biol; 2020 Mar; 21(1):21. PubMed ID: 32228444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
    Ullah K; Zubia E; Narayan M; Yang J; Xu G
    FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-translational regulation of ubiquitin signaling.
    Song L; Luo ZQ
    J Cell Biol; 2019 Jun; 218(6):1776-1786. PubMed ID: 31000580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment.
    Wang Y; Liu X; Huang W; Liang J; Chen Y
    Pharmacol Ther; 2022 Dec; 240():108303. PubMed ID: 36328089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.
    Hosseini SM; Okoye I; Chaleshtari MG; Hazhirkarzar B; Mohamadnejad J; Azizi G; Hojjat-Farsangi M; Mohammadi H; Shotorbani SS; Jadidi-Niaragh F
    Clin Chim Acta; 2019 Nov; 498():126-134. PubMed ID: 31445029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neglected PTM in animal adipogenesis: E3-mediated ubiquitination.
    Ran H; Li C; Zhang M; Zhong J; Wang H
    Gene; 2023 Aug; 878():147574. PubMed ID: 37336271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E3-independent monoubiquitination of ubiquitin-binding proteins.
    Hoeller D; Hecker CM; Wagner S; Rogov V; Dötsch V; Dikic I
    Mol Cell; 2007 Jun; 26(6):891-8. PubMed ID: 17588522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E1 Enzymes as Therapeutic Targets in Cancer.
    Barghout SH; Schimmer AD
    Pharmacol Rev; 2021 Jan; 73(1):1-58. PubMed ID: 33177128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression.
    Sinha A; Iyengar PV; Ten Dijke P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Discovery to Bedside: Targeting the Ubiquitin System.
    Wertz IE; Wang X
    Cell Chem Biol; 2019 Feb; 26(2):156-177. PubMed ID: 30554913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors.
    Li Q; Zhang W
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitination without E3.
    Sorkin A
    Mol Cell; 2007 Jun; 26(6):771-3. PubMed ID: 17588512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.